This article is more than 5 years old. Information may no longer be current.

Allergan to restructure in Europe

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

IRVINE, Calif. — Allergan will consolidate its European operations into facilities in Britain, Ireland and the United States, the company said in a press release earlier this week. The company said potential cost savings were a primary cause for the consolidation.

The restructuring will cost about $50 to $60 million but will not affect the company’s 2004 outlook, its ongoing guidance or the size of its European sales force, the press release said. Expected savings from the restructuring are about $6 to $9 million annually.

The release did not specify which European facilities would be affected. The company currently has operations in Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Spain, Sweden and Switzerland in addition to Ireland and Britain.